Yingyi Long
YOU?
Author Swipe
View article: Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants Open
Accumulating mutations in the SARS-CoV-2 Spike (S) protein can increase the possibility of immune escape, challenging the present COVID-19 prophylaxis and clinical interventions. Here, 3 receptor binding domain (RBD) specific monoclonal an…
View article: Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants Open
Accumulating mutations in the SARS-CoV-2 Spike (S) protein can increase the possibility of immune escape, challenging the present COVID-19 prophylaxis and clinical interventions. Here, 3 receptor binding domain (RBD) specific monoclonal an…
View article: A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2 Open
After the pandemic of COVID-19, neutralizing antibodies (NAbs) against SARS-CoV-2 have been developed for the prophylactic and therapeutic purposes. However, few methodologies are described in detail on how to rapidly and efficiently gener…
View article: Ultrapotent SARS-CoV-2 neutralizing antibodies effectively block new-emerging mutational variants
Ultrapotent SARS-CoV-2 neutralizing antibodies effectively block new-emerging mutational variants Open
Accumulating mutations on SARS-CoV-2 Spike (S) protein may increase the possibility of immune escape, challenging the present COVID-19 prophylaxis and clinical interventions. Here, in a panel of receptor binding domain (S-RBD) specific mon…
View article: A rapid and efficient screening system for neutralizing antibodies and its application for SARS-CoV-2
A rapid and efficient screening system for neutralizing antibodies and its application for SARS-CoV-2 Open
After the epidemic of COVID-19, neutralizing antibodies (NAbs) against SARS-CoV-2 has been developed for the preventative and therapeutic purposes. However, few methodologies are reported in detail on how to rapidly and efficiently generat…
View article: A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD
A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD Open
Neutralizing antibodies (Abs) have been considered as promising therapeutics for the prevention and treatment of pathogens. After the outbreak of COVID-19, potent neutralizing Abs to SARS-CoV-2 were promptly developed, and a few of those n…